Showing results (531-540 of 889) with videos related to
Sort By:
Pageof 89
Drugs in R&D|March 29, 2021
Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After DiscontinuationSophie E Aapkes, Robbert J de Haas, Lucas H P Bernts, et al.Drugs in R&D|February 21, 2015
Auranofin: repurposing an old drug for a golden new ageChristine Roder, Melanie J ThomsonDrugs in R&D|February 6, 2003
Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. fDaoming Qiu, Peter N KaoDrugs in R&D|February 6, 2003
Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled studyTakahide Matsuda, Shigeaki Ohno, Shunsei Hirohata, et al.Drugs in R&D|April 30, 2003
Evaluation of the antiretroviral activity of a new polyherbal drug (Immu-25) in patients with HIV infectionP R Usha, M U R Naidu, Y S N RajuDrugs in R&D|July 10, 2003
Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415Drugs in R&D|November 29, 2002
Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled studyDomenico De Grandis, Chiara MinardiDrugs in R&D|March 21, 2013
Inhibitory effects of azelnidipine tablets on morning hypertensionKazuomi Kario, Yuki Sato, Masayuki Shirayama, et al.Drugs in R&D|December 3, 2011
Efficacy, safety, and palatability of RACTAB(®) formulation amlodipine orally disintegrating tabletsMari Fukui-Soubou, Hirotaka Terashima, Kiyoshi Kawashima, et al.Drugs in R&D|August 17, 2013
Effect of race on left ventricular ejection fraction decline after initial improvement with beta blockers in patients with non-ischemic cardiomyopathy: a retrospective analysisIosif Kelesidis, Patrick Hourani, Christopher Varughese, et al.Pageof 89